Torque Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.11 M
- Company Age 38 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 229.57 Cr
- Satisfied Charges ₹ 68.04 Cr
- Revenue Growth 0.21%
- Profit Growth 13.36%
- Ebitda 12.80%
- Net Worth 22.89%
- Total Assets 10.49%
About Torque Pharmaceuticals
Torque Pharmaceuticals Private Limited (TPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 November 1986 and has a history of 38 years and three months. Its registered office is in Chandigarh, India.
The Corporate was formerly known as Manil Organics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.11 M.
The company currently has active open charges totaling ₹229.57 Cr. The company has closed loans amounting to ₹68.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amariqbal Bedi and Mandeep Singh serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24119CH1986PTC007151
- Company No.
007151
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 1986
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Torque Pharmaceuticals Private Limited offer?
Torque Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cosmetics, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Common Disease Medicines, Pharmaceutical Tablets, Anti Infective Drugs & Medicines, Antiviral Drugs, Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil.
Who are the key members and board of directors at Torque Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Amariqbal Bedi ![]() | Managing Director | 23-Aug-1989 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mandeep Singh ![]() | Director | 05-Nov-2022 | Current |
Financial Performance of Torque Pharmaceuticals.
Torque Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.21% increase. The company also saw a substantial improvement in profitability, with a 13.36% increase in profit. The company's net worth Soared by an impressive increase of 22.89%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Torque Pharmaceuticals?
In 2023, Torque Pharmaceuticals had a promoter holding of 65.34% and a public holding of 34.65%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹229.57 Cr
₹68.04 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 131.38 Cr
- Hdfc Bank Limited : 83.86 Cr
- Tata Capital Financial Services Limited : 7.00 Cr
- Axis Bank Limited : 4.85 Cr
- Others : 2.18 Cr
- Others : 0.30 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Apr 2023 | Axis Bank Limited | ₹7.99 M | Open |
10 Feb 2023 | Axis Bank Limited | ₹1.49 Cr | Open |
06 Jun 2022 | State Bank Of India | ₹6.55 Cr | Open |
23 Feb 2022 | Axis Bank Limited | ₹2.20 Cr | Open |
28 Jan 2022 | Tata Capital Financial Services Limited | ₹2.00 Cr | Open |
How Many Employees Work at Torque Pharmaceuticals?
Torque Pharmaceuticals has a workforce of 1024 employees as of Jul 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Torque Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Torque Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.